MarketCap
Facebook
X
TelegramSeneca Biopharma, Inc. Current Ratio | SNCA
Current Ratio Jährlich Seneca Biopharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.02 | 4.61 | 6.19 | 8.22 | 2.85 | 2.08 | 7.03 | 2.97 | 4.36 | 1.24 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.22 | 1.24 | 4.36 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M |  USA |
 |
Atossa Therapeutics
ATOS
|
5.77 | $ 2.45 | -5.91 % | $ 21.1 M | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
0.955 | $ 16.09 | 2.78 % | $ 1.59 B | USA |
 |
Arcus Biosciences
RCUS
|
8.49 | $ 17.7 | -4.53 % | $ 1.9 B | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
0.794 | $ 0.43 | 0.57 % | $ 5.3 B |  Israel |
 |
Regeneron Pharmaceuticals
REGN
|
4.36 | $ 808.08 | 0.38 % | $ 84.5 B | USA |
 |
Replimune Group
REPL
|
2 | $ 12.48 | 8.9 % | $ 1.16 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
6.37 | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Rafael Holdings
RFL
|
7.25 | $ 1.18 | -9.92 % | $ 34.7 M | USA |
 |
REGENXBIO
RGNX
|
1.29 | $ 6.58 | -1.5 % | $ 339 M | USA |
 |
Kiromic BioPharma
KRBP
|
0.404 | - | 6.61 % | $ 3.08 M | USA |
 |
Rigel Pharmaceuticals
RIGL
|
4.21 | $ 49.95 | 3.78 % | $ 898 M | USA |
 |
Compugen Ltd.
CGEN
|
7.46 | $ 1.89 | -2.84 % | $ 177 M | Israel |
 |
Relay Therapeutics
RLAY
|
11.4 | $ 18.16 | -0.11 % | $ 3.12 B | USA |
 |
Coherus BioSciences
CHRS
|
1.31 | $ 1.0 | -0.5 % | $ 117 M | USA |
 |
Calithera Biosciences
CALA
|
3.46 | - | -10.95 % | $ 876 K | USA |
 |
Royalty Pharma plc
RPRX
|
1.98 | $ 64.76 | 1.4 % | $ 27.8 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
2.28 | $ 89.56 | 0.32 % | $ 5.82 B | USA |
 |
Rezolute
RZLT
|
9.28 | $ 3.82 | -1.04 % | $ 397 M | USA |
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Aprea Therapeutics
APRE
|
9.42 | $ 0.43 | -16.94 % | $ 2.81 M | USA |
 |
Sana Biotechnology
SANA
|
1.63 | $ 2.36 | 1.29 % | $ 598 M | USA |
 |
Molecular Templates
MTEM
|
1.14 | - | -23.43 % | $ 495 K | USA |
 |
PDS Biotechnology Corporation
PDSB
|
1.44 | $ 1.07 | -4.05 % | $ 49.6 M | USA |
 |
BioXcel Therapeutics
BTAI
|
0.32 | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Seer
SEER
|
8.05 | $ 1.93 | -2.03 % | $ 107 M | USA |
 |
CohBar
CWBR
|
15.8 | - | -15.44 % | $ 2.2 M | USA |
 |
SIGA Technologies
SIGA
|
10.6 | $ 3.16 | 1.12 % | $ 226 M | USA |
 |
NeuBase Therapeutics
NBSE
|
3.48 | - | -1.56 % | $ 12.3 M | USA |
 |
Olema Pharmaceuticals
OLMA
|
9.72 | $ 6.61 | 3.04 % | $ 575 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
4.21 | $ 70.54 | 1.57 % | $ 197 M | Israel |
|
Silence Therapeutics plc
SLN
|
1.12 | $ 19.77 | 0.48 % | $ 2.8 B |  Britain |
 |
Deciphera Pharmaceuticals
DCPH
|
3.86 | - | - | $ 2.18 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | USA |
 |
Scopus BioPharma
SCPS
|
0.519 | - | -48.37 % | $ 3.71 M | USA |
 |
Syndax Pharmaceuticals
SNDX
|
1.14 | $ 13.21 | -1.42 % | $ 1.14 B | USA |
 |
Soligenix
SNGX
|
2.34 | $ 0.35 | -4.08 % | $ 1.82 M | USA |
 |
scPharmaceuticals
SCPH
|
1.14 | - | - | $ 218 M | USA |
 |
Spruce Biosciences
SPRB
|
5.05 | $ 43.74 | -3.12 % | $ 33.5 M | USA |
 |
Spero Therapeutics
SPRO
|
6.96 | $ 1.07 | -4.05 % | $ 59.9 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
4.22 | - | - | $ 105 M | USA |
 |
Athersys
ATHX
|
2.11 | - | 3.77 % | $ 22.4 M | USA |
 |
Sarepta Therapeutics
SRPT
|
1.52 | $ 17.99 | 0.73 % | $ 1.8 B | USA |
 |
Global Blood Therapeutics
GBT
|
1.26 | - | - | $ 4.62 B | USA |
 |
Sutro Biopharma
STRO
|
0.568 | $ 8.79 | -5.79 % | $ 74.7 M | USA |
 |
Shattuck Labs
STTK
|
10.5 | $ 5.55 | 1.09 % | $ 386 M | USA |
 |
Supernus Pharmaceuticals
SUPN
|
3.72 | $ 40.79 | 0.22 % | $ 2.3 B | USA |
 |
Savara
SVRA
|
5.04 | $ 4.53 | 7.23 % | $ 1.01 B | USA |
 |
China SXT Pharmaceuticals
SXTC
|
6.89 | $ 3.49 | -14.88 % | $ 2.37 M |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
1.95 | $ 20.45 | 1.01 % | $ 32.3 B |  Japan |